Skip to main content

Table 1 Patient characteristics

From: Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease

Demographics
 Number 57
 Age (y) 34 (26–47)
 Female 48/9
 Disease duration (months) 3 (1–12)
Clinical features
 Fever > 39 °C 46 (80.7)
 Skin rash 52 (91.2)
 Arthralgia 52 (91.2)
 Sore throat 44 (77.2)
 Lymphadenopathy 43 (75.4)
 Splenomegaly 25 (43.9)
 Hepatomegaly 9 (15.8)
 Pleuritis 20 (35.1)
 Pericarditis 14 (24.6)
 Weight loss 14 (24.6)
 Lung disease 1 (1.8)
Laboratory findings
 Leukocytosis (> 10,000/mm3) 34 (59.7)
 Neutrophils (> 80%) 36 (63.2)
 Hb < 90 g/L 9 (15.8)
 PLT < 100,000/mm3 2 (3.5)
 ESR > 40 mm/h 42 (73.7)
 CRP > ULN 54 (94.7)
 Serum ferritin > 5 ULN 36 (63.2)
 Abnormal liver function 36 (63.2)
 Negative ANA (titer ≤ 1:80) 54 (94.7)
 Negative RF 56 (98.2)
 IL2R > ULN 33/45 (73.3)
 Pouchot score 7 (5–7.5)
  1. Data are presented in the form of median (Q1–Q3) as continuous variable or as absolute number (percentage of the total patients%);
  2. ULN upper limit of normal, Hb hemoglobin, PLT platelet, ESR erythrocyte sedimentation rate, ANA antinuclear antibody, RF rheumatoid factor, CRP C-reactive protein, IL-2R interleukin-2 receptor